Life sciences regulatory & compliance partner Al Cacozza (Washington, D.C.) co-authored a Law360 article that reviews incentives and risks for the over-the-counter (OTC) drug system overhaul under the CARES Act of the coronavirus stimulus legislation.
The authors analyze the key provisions of the OTC monograph including an outline of the status of currently marketed OTC monograph drugs, a new administrative process to establish or amend a monograph, including expedited procedures for imminent public health hazards, an 18-month exclusivity period for certain administrative orders, creation of a user fee program, and proposed modifications to the Sunscreen Innovation Act of 2014.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.